Genitourinary syndrome of menopause statement stresses treatment optionsOctober 22, 2020Women's HealthEndocrinology
Fetal estrogens show promise for safer therapy for menopauseOctober 22, 2020Women's HealthEndocrinology
COVID-19 antibody response not reduced with diabetesOctober 20, 2020DiabetesCOVID-19 UpdatesInfectious DiseasesEndocrinology
T2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020DiabetesPreventive CareCardiologyEndocrinology
Adrenal vein sampling looms as choke point for aldosteronism assessment of hypertensivesOctober 12, 2020EndocrinologyCardiology
Empagliflozin cut PA pressures in heart failure patientsOctober 12, 2020CardiologyPulmonologyDiabetesEndocrinology
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartanOctober 6, 2020DiabetesCardiologyEndocrinology
Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020DiabetesEndocrinologyCardiologyNephrology
AHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020DiabetesCardiologyEndocrinology
New data challenge primary care’s inattention to aldosterone in hypertensionOctober 1, 2020CardiologyEndocrinology
Higher glycemic time in range may benefit T2D patientsSeptember 28, 2020DiabetesCardiologyEndocrinology
Exercise cuts diabetes death risk by a third in two studiesSeptember 28, 2020DiabetesCardiologyEndocrinology
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor useSeptember 25, 2020DiabetesMixed TopicsNephrologyEndocrinologyCardiology
